test
Menu
Close
Menu
Menu
Pogust Goodhead is currently litigating against the manufacturers of EzriCare and Delsam Pharma’s Artificial Tears in the US, and, this week, the Wall Street Journal has published a feature on the lawsuit and our client, Beverly Jennings.
On 9 June 2023, NHS England published an interim service specification which outlines the aims of Gender Incongruence treatment services and the clinical approaches to treatment which should be adopted going forwards.
Over the weekend, the Pogust Goodhead team had the pleasure of joining the 2023 Brazil Forum UK held at the University of Oxford.
Pogust Goodhead (a trading name of PGMBM Law Ltd) SRA License Number 512898.
Pogust Goodhead is authorised and regulated by the Solicitors Regulation Authority and complies with the Solicitors Code of Conduct, a copy of which can be located here.
VAT No: 974 7183 77
